Cargando…
Recent Advances in Meningioma Immunogenetics
Meningiomas are relatively common, and typically benign intracranial tumors, which in many cases can be cured by surgical resection. However, less prevalent, high grade meningiomas, grow quickly, and recur frequently despite treatment, leading to poor patient outcomes. Across tumor grades, subjectiv...
Autores principales: | Al-Rashed, May, Foshay, Kara, Abedalthagafi, Malak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960175/ https://www.ncbi.nlm.nih.gov/pubmed/31970090 http://dx.doi.org/10.3389/fonc.2019.01472 |
Ejemplares similares
-
Immunogenetics of glioblastoma: the future of personalized patient management
por: Abedalthagafi, Malak, et al.
Publicado: (2018) -
Recent advances in the molecular prognostication of meningiomas
por: Wang, Elaina J., et al.
Publicado: (2023) -
Epigenomics and immunotherapeutic advances in pediatric brain tumors
por: Abedalthagafi, Malak, et al.
Publicado: (2021) -
Recent advances in the immunogenetics of idiopathic inflammatory myopathy
por: Chinoy, Hector, et al.
Publicado: (2011) -
Bone Invasive Meningioma: Recent Advances and Therapeutic Perspectives
por: Takase, Hajime, et al.
Publicado: (2022)